HY-109091-100mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091-5mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091-50mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091-1mL
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-19672-10mg
|
MedChemexpress LLC
|
Lirimilast [CAS 329306-27-6]
|
|
COVID-19-immunoregulation
|
|
HY-19672-5mg
|
MedChemexpress LLC
|
Lirimilast [CAS 329306-27-6]
|
|
COVID-19-immunoregulation
|
|
HY-19672-1mL
|
MedChemexpress LLC
|
Lirimilast [CAS 329306-27-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|